In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor.

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...

Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors and sometimes eliminating them entirely.

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

Saved from precursor B-cell acute lymphoblastic leukemia, the Nobel Prize winning CAR T-cell therapy gave Bryn Ailinger a ...

Almost all stomach cancers are adenocarcinomas. But some rarer types may be more aggressive, affecting your treatment options and outlook. Stomach cancer (or gastric cancer) happens when cancerous ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

A little over a month after revealing to the world that she'd been diagnosed with cancer, Tatiana Schlossberg has died at age ...